Treatment for Glaucoma

Phase-Based Progress Estimates
Illinois College of Optometry, Chicago, IL
Glaucoma+2 More
All Sexes
What conditions do you have?

Study Summary

The objective of this study is to collect stereo-optic disc photographs for potential future analysis.

Eligible Conditions

  • Glaucoma
  • Normal
  • Retina Disease

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 1 year

1 year
Bland-Altman Plots of Stereo Disc Photos, SLO images and OCT Scans
Deming Regression of Stereo Disc Photos, SLO images and OCT Scans

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

125 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year
Closest Location: Illinois College of Optometry · Chicago, IL
Photo of Chicago  1Photo of Chicago  2Photo of Chicago  3
2015First Recorded Clinical Trial
2 TrialsResearching Glaucoma
6 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are 22 years of age or older.
You are able to understand the written informed consent and willing to participate as evidenced by signing the informed consent.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.